AVDL
Avadel Pharmaceuticals
AVDL
AVDL
127 hedge funds and large institutions have $1.17B invested in Avadel Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 43 increasing their positions, 29 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 112 → 127 (+15)
13.11% more ownership
Funds ownership: 63.57% → 76.68% (+13%)
46% less call options, than puts
Call options by funds: $24.3M | Put options by funds: $45.1M
Holders
127
Holding in Top 10
10
Calls
$24.3M
Puts
$45.1M
Top Buyers
| 1 | +$45.1M | |
| 2 | +$31.3M | |
| 3 | +$30.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$28.5M |
| 5 |
Millennium Management
New York
|
+$27.2M |
Top Sellers
| 1 | -$23.2M | |
| 2 | -$22.3M | |
| 3 | -$7.97M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.94M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.04M |